217 related articles for article (PubMed ID: 11781659)
1. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells.
Takebe N; Zhao SC; Ural AU; Johnson MR; Banerjee D; Diasio RB; Bertino JR
Cancer Gene Ther; 2001 Dec; 8(12):966-73. PubMed ID: 11781659
[TBL] [Abstract][Full Text] [Related]
2. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
[TBL] [Abstract][Full Text] [Related]
4. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells.
Zhou SZ; Broxmeyer HE; Cooper S; Harrington MA; Srivastava A
Exp Hematol; 1993 Jul; 21(7):928-33. PubMed ID: 8391471
[TBL] [Abstract][Full Text] [Related]
6. Increased efficiency of gene transfer with retroviral vectors in neonatal hematopoietic progenitor cells.
al-Lebban ZS; Henry JM; Jones JB; Eglitis MA; Anderson WF; Lothrop CD
Exp Hematol; 1990 Mar; 18(3):180-4. PubMed ID: 2303110
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
[TBL] [Abstract][Full Text] [Related]
8. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.
Allay JA; Koç ON; Davis BM; Gerson SL
Clin Cancer Res; 1996 Aug; 2(8):1353-9. PubMed ID: 9816307
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of mutant dihydrofolate reductase gene on human peripheral blood CD34+ cells against methotrexate].
Wu R; Yang Z; Liu J
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):186-9. PubMed ID: 11776831
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
[TBL] [Abstract][Full Text] [Related]
12. [In vitro study on the transduction of mutant human dihydrofolate reductase cDNA into human umbilical cord blood CD34+ cells].
Wu R; Yang Z; Liu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):140-2. PubMed ID: 11601241
[TBL] [Abstract][Full Text] [Related]
13. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
[TBL] [Abstract][Full Text] [Related]
14. Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA.
Flasshove M; Banerjee D; Leonard JP; Mineishi S; Li MX; Bertino JR; Moore MA
Hum Gene Ther; 1998 Jan; 9(1):63-71. PubMed ID: 9458243
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.
Huang MM; Wong A; Yu X; Kakkis E; Kohn DB
Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity.
Kouwaki M; Hamajima N; Sumi S; Nonaka M; Sasaki M; Dobashi K; Kidouchi K; Togari H; Wada Y
Clin Cancer Res; 1998 Dec; 4(12):2999-3004. PubMed ID: 9865912
[TBL] [Abstract][Full Text] [Related]
18. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.
Wang JS; Fang Q; Sun DJ; Chen J; Zhou XL; Lin GW; Lu HZ; Fei J
Acta Pharmacol Sin; 2001 Oct; 22(10):949-55. PubMed ID: 11749781
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Fluorouracil-inducible GM-CSF gene therapy regulated by Egr-1 promoter on chemotherapeutic hematopoietic damage of tumor-bearing mice].
Du N; Pei XT; Xiao WH; Sun JZ; Fu Y; Zhao H; Wang XL
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1281-6. PubMed ID: 19595187
[TBL] [Abstract][Full Text] [Related]
20. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
